These industrial stocks are expected to benefit in the near term.
AGP raised to Buy at Jefferies.CCO raised to Outperform at Bear Stearns.DELL started as Buy at WRHambrecht.DLTR raised to Outperform at Wachovia.DRI raised to Outperform at CIBC.EQT started as BUy at...
ADCT raised to Outperform at Baird.ALVR started as Mkt Perform at Piper Jaffray.AMSC cut to Underperform at RBC.DTV raised to Neutral at Credit Suisse.EAT raised to Overweight at JPMorgan.ELX raised...
Flex Pharma Inc. has filed with the Securities and Exchange Commission (SEC) for its initial public offering.
This report was sent to Briefing.com subscribers earlier today.  Research calls posted earlier this morning are available here.   Upgrades: > Colgate-Palmolive (CL) upgraded to Overweight from...
Thursday's leading analyst upgrades, downgrades and initiations from top research calls from around Wall Street include Eaton, Checkpoint Software, eBay, Emerson, Honeywell and SanDisk.
(BDY) Bradley Pharma said its special committee has received bid indications in its attempt of exploring strategic alternatives.(CFC) Countrywide Financial down over 10% after disclosures in SEC...
With the quarter winding down, so to are the windows for insiders to make transactions before earnings are reported. We saw a definite volume drop this week.
As the markets continue to stumble through May, and the volatility appears to be creeping up some, the end of the first-quarter earnings parade has opened the door for insiders to buy shares.
The first quarter was a busy one for insider buying. While it remains to be seen how this quarter will be, the overall tone of insider activity remains positive.
After a week when the indexes finally fought their way back to even for 2016, one probably would think that insiders would be selling the huge rally. Just the opposite happened.
Tuesday's top analyst upgrades, downgrades, and initiations include Apple, AMC Networks, BP, LendingClub, Monster Beverage and Seagate Technology.
After U.S. markets close Monday afternoon, 58 companies are scheduled to report quarterly earnings results. The following table is based on data from Briefing.com and includes a consensus forecast in...
247 Wall St. could not help but notice four analyst calls this past week in which upside of 50% to 100% was predicted for four biotech and specialty pharma stocks.
We cover insider selling each week at 24/7 Wall St., and despite the big numbers and share counts that are starting to hit the tape, there is no immediate reason for alarm.